Island Pharmaceuticals Ltd — Form D
Island Pharmaceuticals Ltd of CAMBERWELL, C3, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-05. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-06-05
- Form: D
- Accession: 0000898432-24-000462
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $1.2M
- Amount sold: $1.2M
- Investors: 4
- Date of first sale: 2024-03-05
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-515176
Issuer
- Name: Island Pharmaceuticals Ltd
- CIK: 0002012855
- Entity type: Corporation
- Jurisdiction: AUSTRALIA
- Incorporated: 2020
- Address: SUITE 201, 697 BURKE ROAD, CAMBERWELL, C3, 3124
- Phone: 61390920475
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Brookes | Director | Camberwell, C3 |
| David Foster | Director | Camberwell, C3 |
| Albert Hansen | Director | Newport Beach, CA |
| Paul MacLeman | Director | Camberwell, C3 |
| Nick McCoy | Executive Officer | Camberwell, C3 |
More